I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC)

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 427-432

  Bayerlein, K ^a   Rith, T ^a   Verdorfer, I ^a   Liehr, T ^b   Wolff, E ^a   Girod, S ^a   Gebhart, E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

CGH; DNA sequence copy number amplifications; FISH; Oral squamous cell carcinomas (OSCC)

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 9Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA PROBE; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERPHASE; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DNA, NEOPLASM; FEMALE; GENE DUPLICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; PARAFFIN EMBEDDING;

EID: 0034077292     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Adnane J, Gaudray P, Simon MP, Simony-Lafontaine J, Jeanteur P and Theillet C: Proto-oncogene amplification and human breast phenotype. Oncogene 4: 1389-1395, 1989.
2. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F and Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 over-expression. Cancer 79: 380-389, 1997.
3. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky C, Pritzker KP, Hartwick RW, Lickley HW, Wilkinson R, Qizilbash A. Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W and McCready D: Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16: 1340-1349, 1998.
4. Auhele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, Höfler H and Werner M: Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 110: 94-102, 1999.
5. Barrios C, Castresana JS, Falkner UG, Rosendahl I and Krelebergs A: C-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms. Int J Cancer 58: 781-786, 1994.
6. Becker I, Becker KF, Röhrl MH, Minkus G, Schütze K, Höfler H: Single-cell mutation analysis of tumors from stained histologic slides. Lab Invest 75: 801-807, 1996.
7. Brandt B, Vogt U, Schlotter CM, Jackisch C, Werkmeister R, Thomas M, von Eiff M, Bosse U, Assmann G and Zanker KS: Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 159: 135-142, 1995.
8. Brison O: Gene amplification and tumor progression. Biochim Biophys Acta 1155: 25-41, 1983.
9. Bui TD, Beier DR, Jonssen M, Smith K, Dorrington SM, Kaklamanis L, Kearney L, Regan R, Sussman DL, Harris AL: cDNA cloning of a human dishevelled DVL-3 gene, mapping to 3q27 and expression in human breast and colon carcinomas. Biochem Biophys Res Comm 239: 510-516, 1997.
10. Chaganti SR, Chen W, Parsa N, Offit K, Louie DC, Dalla-Favera R and Chaganti RSK: Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell Non-Hodgkin lymphoma. Genes Chrom Cancer 23: 323-327, 1998.
11. Collins SJ and Groudine MT: Rearrangement and amplification of cabl sequences in the human chronic myclogenous leukemia cell line K-562. Proc Natl Acad Sci USA 80: 4813-4818, 1983.
12. Dallery E, Galiegue-Zouitina S, Collyn-d'Hooghe M, Quief S, Denis C, Hildebrand MP, Lantoine D, Deweindt C, Tilly H and Bastard C: TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene 10: 2171-2178, 1995.
13. Fajac A, Benard J, Lhomme C, Rey A, Duvillard P, Rochard F, Barnaudin JF and Riou G: C-erb B2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int J Cancer 64: 146-1561, 1995.
14. Fernandez JL, Goyanes V, Lopez-Fernandez C, Buno I and Gosalvez J: Quantification of c-ERB-B2 gene amplification in breast cancers using fluorescence in situ hybridization and digital image analysis. Cancer Genet Cytogenet 86: 18-21, 1996.
15. Gebhart E, Liehr T, Wolff E, Ries J, Fiedler W, Steininger H, Koscielny S and Girod S: Pattern of genomic imbalances in oral squamous cell carcinomas with and without an increased copy number of 11q13. Int J Oncol 12: 1151-1155, 1998.
16. Heselmeyer K, Schröck E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93: 479-484, 1996.
17. James LA, Ogilvie DJ, Yamakawa K, Nakamura Y, Stirling CJ and Anand R: Walking, cloning and mapping with YACs in 3q27: localization of five ESTs including three members of the cystatin gene family and identification of CpG islands. Genomics 32: 425-430, 1996.
18. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J and Cardesa A: PRAD1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 813-4818, 1994.
19. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D and Gray JW: ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Nat Acad Sci USA: 89: 5321-5325, 1992.
20. Kenner L, Beham-Schmid C. Kerbl R, Schmidt HH, Sill H and Hoefler G: Abl amplification in a patient with lymphoid blast crisis of chronic myelogenous leukemia. Virchows Arch 434: 255-257, 1999.
21. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G and Bastard C: LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5: 66-70, 1993.
22. Kozma L, Kiss I, Szakall S and Ember I: Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett 81: 165-169, 1994.
23. Kumagai T, Miki T, Kikuchi M, Fukuda T, Miyasaka N, Kamiyama R and Hirosawa S: The proto-oncogene Bc 16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells. Oncogene 18: 467-475, 1999.
24. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson JT, Myers EN and Gollin SM: Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chrom Cancer 12: 288-295, 1995.
25. Liehr T, Grehl H and Rautenstrauß B: FISH analysis of interphase nuclei extracted from paraffin-embedded tissue. Trends in Genetics 11: 377-378, 1995.
26. Liehr T, Stübinger A, Thoma K, Tulusan HA and Gebhart E: Comparative interphase cytogenetics using FISH on human ovarian carcinomas. Anticancer Res 14: 183-188, 1994.
27. Lönn U, Lönn S, Nilsson D and Stenkvist B: Breast cancer: prognostic significance of c-erbB2 and int-2 amplification compared with DNA ploidy, S-phase fraction and conventional clinicopathological features. Breast Cancer Res Treat 29: 237-245, 1994.
28. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner B, Dickinson Caddle S, Ziaugra L, Beijershergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997.
29. Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, Mc Blain WA, Slamon DJ and Fourney RM: Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 51: 556-567, 1991.
30. Pauletti G, Godolphin W, Press M and Slamon DJ: Detection and quantitation of HER-2 neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996
31. Persons DJ, Borelli KA and Hsu PH: Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod Pathol 10: 720-727, 1997
32. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR and Flom KJ: HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas. J Clin Oncol 15: 2894-2904, 1997.
33. Rizzu P and Baldini A: Three members of the human cystatin gene superfamily, ASHG, HRG and KNG, map within one megabase of genomic DNA at 3q27. Cytogenet Cell Genet 21: 26-28, 1995.
34. Sauter G, Feichter G, Torhorst J, Moc H, Novotna H, Wagner U, D̈rrmüller U and Waldman FM: Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol 40: 164-173, 1996.
35. Schuuring E: The involvement of the chromoostne 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159: 83-96, 1995.
36. Schwab M, and Amler LC: Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chrom Cancer I: 181-193, 1990.
37. Scully C and Field JK: Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (review). Int J Oncol 10: 5-21, 1997.
38. Sheyn I, Noffsinger AE, Heffelfinger S, Davis B, Miller MA and Fenoglio-Preiser CM: Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol 28: 270-276, 1997.
39. Simpson JF, Quan DE, O'Malley F, Odom-Maryon T and Clarke PE: Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151: 161-168, 1997.
40. Slamon DJ, Clark GM, Wong SG , Levin WJ, Ullrich A and Mc Guire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
41. Tanner MM, Karhu RA, Nupponen NN, Borg A, Baldetorp B, Pejovic T, Ferno M, Killander D and Isola JJ: Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. Am J Pathol 153: 191-199, 1998.
42. Taubald A, Liehr T, Ries J, Girod S, Hassfurter E and Gebhart E: CGH-detected DNA sequence copy number amplifications can be confirmed by interphase-FISH: New possibilities for prognostic-approaches in oral squamous carcinomas. Int J Mol Med 2: 555-560, 1998.
43. Van Cong N, Fichelson S, Gross MS, Sola B, Bordereaux D, de Tand MF, Guilhot S, Gisselbrecht S, Frezal J and Tanbourin P: The human homologues of Fim1,Fim2/c-Fms and Fim3, three retroviral integration regions involved in mouse myeloblastic leukemias, are respectively located on chromosomes 6p23, 5q33 and 3q27. Hum Genet 81: 257-263, 1989.
44. Werkmeister R, Brandt B and Joos U: The erbB oncogenes as prognostic markers in oral squamous cell carcinomas. Am J Surg 172: 681-683, 1996
45. Wolff E, Liehr T, Vorderwülbecke U, Tulusan AH, Husslein EM and Gebhart E: Frequent gains and losses of specific chromosome segments in human ovarian carcinomas shown by comparative genomic hybridization. Int J Oncol 11: 19-23, 1997.
46. Wolff E, Girod S, Liehr T, Vorderwülbecke U, Ries J, Steininger H and Gebhart E: Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridization. Eur J Cancer 34: 186-190, 1998.
47. Xing WR, Gilchrist KW, Harris CP, Samson W and Meisner LF: FISH detection of HER-2/neu oncogene amplification in early onset breast cancer. Breast Cancer Res Treat 39: 203-212, 1996.
48. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS and Dalla-Favera R: Alterations of a zinc-finger-encoding gene. BCL-6, in diffuse large-cell lymphoma. Science 262: 747-750, 1993.
49. Zhou DJ, Casey G and Cline MJ: Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 2: 279-282.
50. Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA: A microdissection technique for archival DNA analysis of specific cell populations in lesions <1mm in size. Am J Pathol 146: 620-625, 1995.